SCHEMBL6707724

SCHEMBL6707724

O=C(CSc1ccccc1)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3nnn[nH]3)[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.41
TP53 P04637 1/20 0.41
MAPK1 P28482 1/20 0.41
MAPT P10636 6/20 0.40
HTT P42858 2/20 0.40
KMT2A Q03164 3/20 0.39
RXFP1 Q9HBX9 1/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
RECQL P46063 1/20 0.38
NHERF1 O14745 2/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709834 0.91 MAPT (0.40) L3MBTL1TP53MAPTHTTKMT2A
SCHEMBL6710181 0.88 L3MBTL1 (0.43) L3MBTL1MAPK1MAPTHTTKMT2A
SCHEMBL6708820 0.88 PARP14 (0.41) L3MBTL1TP53MAPK1KMT2ASMN1; SMN2
SCHEMBL6713754 0.87 SERPINE1 (0.43) L3MBTL1RXFP1KDM4ENHERF1PLCG2
SCHEMBL6714040 0.87 F10 (0.38) L3MBTL1TP53MAPK1MAPTRAB9A
SCHEMBL6709211 0.87 PLCG2 (0.39) TP53MAPTKMT2ARXFP1LMNA
SCHEMBL6710087 0.87 PLCG2 (0.39) TP53MAPK1MAPTKMT2ARAB9A
SCHEMBL6714114 0.86 ALOX15 (0.45) L3MBTL1MAPK1KMT2ASMN1; SMN2LMNA
SCHEMBL6712023 0.86 RAB9A (0.46) L3MBTL1TP53MAPTHTTKMT2A
SCHEMBL6710315 0.85 POLB (0.39) TP53MAPK1MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 L3MBTL1 2013/4885TP53 2699/4885MAPK1 2728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.